Hartford Financial Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $805K | Buy |
1,637
+30
| +2% | +$16.3K | 0.21% | 81 |
|
|
2025
Q4 | $931K | Sell |
1,607
-21
| -1% | -$11.9K | 0.24% | 79 |
|
|
2025
Q3 | $790K | Sell |
1,628
-125
| -7% | -$58.2K | 0.21% | 82 |
|
|
2025
Q2 | $711K | Sell |
1,753
-753
| -30% | -$315K | 0.19% | 88 |
|
|
2025
Q1 | $1.25M | Sell |
2,506
-26
| -1% | -$14.1K | 0.26% | 100 |
|
|
2024
Q4 | $1.32M | Buy |
2,532
+92
| +4% | +$50.6K | 0.27% | 100 |
|
|
2024
Q3 | $1.51M | Sell |
2,440
-142
| -5% | -$84.1K | 0.31% | 94 |
|
|
2024
Q2 | $1.43M | Buy |
2,582
+1,111
| +76% | +$636K | 0.31% | 91 |
|
|
2024
Q1 | $855K | Buy |
1,471
+367
| +33% | +$206K | 0.18% | 113 |
|
|
2023
Q4 | $586K | Buy |
1,104
+1
| +0.1% | +$484 | 0.13% | 126 |
|
|
2023
Q3 | $558K | Buy |
1,103
+1
| +0.1% | +$533 | 0.14% | 127 |
|
|
2023
Q2 | $575K | Hold |
1,102
| – | – | 0.14% | 125 |
|
|
2023
Q1 | $635K | Buy |
1,102
+2
| +0.2% | +$1.13K | 0.16% | 124 |
|
|
2022
Q4 | $606K | Hold |
1,100
| – | – | 0.16% | 125 |
|
|
2022
Q3 | $558K | Hold |
1,100
| – | – | 0.16% | 124 |
|
|
2022
Q2 | $598K | Hold |
1,100
| – | – | 0.17% | 122 |
|
|
2022
Q1 | $650K | Hold |
1,100
| – | – | 0.16% | 120 |
|
|
2021
Q4 | $734K | Sell |
1,100
-11
| -1% | -$6.87K | 0.17% | 116 |
|
|
2021
Q3 | $635K | Buy |
1,111
+11
| +1% | +$6.04K | 0.16% | 114 |
|
|
2021
Q2 | $555K | Buy |
+1,100
| New | +$519K | 0.14% | 121 |
|
|
2018
Q3 | – | Sell |
-64
| Closed | -$13K | – | 423 |
|
|
2018
Q2 | $13K | Hold |
64
| – | – | ﹤0.01% | 303 |
|
|
2018
Q1 | $13K | Buy |
+64
| New | +$13.4K | 0.01% | 252 |
|
|
2017
Q4 | – | Sell |
-64
| Closed | -$12K | – | 377 |
|
|
2017
Q3 | $12K | Hold |
64
| – | – | 0.01% | 284 |
|
|
2017
Q2 | $11K | Hold |
64
| – | – | ﹤0.01% | 278 |
|
|
2017
Q1 | $9K | Hold |
64
| – | – | 0.01% | 274 |
|
|
2016
Q4 | $9K | Hold |
64
| – | – | 0.01% | 248 |
|
|
2016
Q3 | $10K | Hold |
64
| – | – | 0.01% | 239 |
|
|
2016
Q2 | $9K | Hold |
64
| – | – | 0.01% | 223 |
|
|
2016
Q1 | $9K | Hold |
64
| – | – | 0.01% | 216 |
|
|
2015
Q4 | $9K | Hold |
64
| – | – | 0.01% | 214 |
|
|
2015
Q3 | $7K | Hold |
64
| – | – | ﹤0.01% | 212 |
|
|
2015
Q2 | $8K | Buy |
+64
| New | +$8.34K | ﹤0.01% | 223 |
|
|
2015
Q1 | – | Sell |
-64
| Closed | -$8K | – | 207 |
|
|
2014
Q4 | $8K | Hold |
64
| – | – | ﹤0.01% | 201 |
|
|
2014
Q3 | $7K | Hold |
64
| – | – | ﹤0.01% | 228 |
|
|
2014
Q2 | $7K | Hold |
64
| – | – | ﹤0.01% | 233 |
|
|
2014
Q1 | $7K | Hold |
64
| – | – | ﹤0.01% | 213 |
|
|
2013
Q4 | $7K | Hold |
64
| – | – | ﹤0.01% | 208 |
|
|
2013
Q3 | $5K | Hold |
64
| – | – | ﹤0.01% | 233 |
|
|
2013
Q2 | $5K | Buy |
+64
| New | +$5.33K | ﹤0.01% | 234 |
|
Other funds holding TMO
VCM
Hartford Financial Management's TMO Position: Q1 2026 in Review
Hartford Financial Management increased its Thermo Fisher Scientific (TMO) stake by 1.9% in Q1 2026, buying an estimated $16.3K and bringing the position to 1,637 shares worth $805K. The position accounts for 0.21% of the portfolio, ranked #81.
Hartford Financial Management first reported a position in TMO in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.51M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Hartford Financial Management held 1,637 shares of Thermo Fisher Scientific worth $805K as of Q1 2026.
- Hartford Financial Management bought 30 Thermo Fisher Scientific shares in Q1 2026, an estimated $16.3K.
- Thermo Fisher Scientific made up 0.21% of Hartford Financial Management's portfolio in Q1 2026, its #81 holding.
- Hartford Financial Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 39 quarters since.
- Hartford Financial Management's Thermo Fisher Scientific position peaked at $1.51M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.